 Cardiovascular antiarrhythmic effects esmolol children prospective study cardiovascular antiarrhythmic effects esmolol intravenous beta-blocker short half-life patients years underwent diagnostic electrophysiologic studies rest beta-blockade induced esmolol initial dose micrograms/kg minutes infusion micrograms/kg minute dosage micrograms/kg minute minutes reduction heart rate blood pressure dosage beta-blockade micrograms/kg minute mean micrograms/kg minute Electrophysiologic effects decrease rate sinoatrial node discharge delay conduction atrioventricular node effect His-Purkinje conduction Atrial ventricular effective refractory periods unchanged patients supraventricular tachycardia prevented induction tachycardia rate tachycardia patients ventricular tachycardia clinical findings unchanged rate blood pressure baseline values minutes esmolol infusion Adverse ventricular electrophysiologic effects patients biopsy evidence myocarditis adverse effects effects esmolol children similar beta-blockers useful evaluation management pediatric tachyarrhythmias weight-adjusted dosage beta-blockade children adult dosage effects esmolol dissipate